Surgical Intelligence platform Theator secured $15.5M in Series A funding

Theator, a California-based Surgical Intelligence platform leveraging Artificial Intelligence and Computer Vision to improve surgeon performance, has now secured $15.5 million in a Series A funding round.

Theator is founded by Dr. Tamir Wolf. It is a provider of AI-powered Surgical Intelligence solutions. Its platform is based on video analytics and smart annotation technology, which extracts and annotates key moments from surgical procedures, enabling surgeons to review operations and glean detailed insights within minutes.

Dr. Tamir Wolf, CEO and Co-founder of Theator, said, "Intraoperative video footage, and by extension video-based analyses, is at the core of surgical innovation. Surgeons, medical systems and forward-thinking professional societies have all come to realize its potential value in enhancing surgical care and patient safety. Thanks to support from our new and existing investors, Theator is leveraging routine video capture and AI-based analyses of surgical data to build a surgical future where best practices are more widely understood, and surgical decision-making is democratized."

Jeff Horing, Co-Founder and Managing Director at Insight Partners, said, "Theator is at the forefront of game-changing surgical field advances, and we are thrilled to support such an exciting company as it strengthens its market foothold. The company has a proven track record of applying its world-class AI and computer vision expertise to enhance surgery, aiming to create a win-win scenario in which patients, hospitals, surgeons, and insurers all benefit, and we look forward to witnessing the company's continued growth and development as it continues to lead the world of video analytics in surgery."

The Insight Partners led the latest funding round.  Other participating investors include Blumberg Capital and supported by all existing investors namely iAngels, StageOne Ventures, NFX, and KdT Ventures. To date, the company secured a total of $18.5 million. 

Theator plans to leverage newly raised funds to scale its commercial operations and partnerships with the US providers and grow its Research & Development team, notes the announcement.